Yolanda Bryce, MD

Assistant Attending
Memorial Sloan Kettering Cancer Center

Presentation(s):

• Healthcare Disparities in Interventional Radiology

  Monday, March 6, 2023
  2:30 PM – 3:00 PM

  Disclosure information not submitted.

• Long-term outcomes of PET-guided Microwave Ablation of Breast Cancer Liver Metastases

  Monday, March 6, 2023
  3:54 PM – 4:03 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• Breast Cancer Cryoablation: Practice Development and Clinical Trial Updates

  Tuesday, March 7, 2023
  9:10 AM – 9:20 AM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• Peripheral Arterial Disease (PAD)

  Tuesday, March 7, 2023
  3:00 PM – 4:30 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• Language of bias

  Tuesday, March 7, 2023
  5:00 PM – 6:00 PM

  Disclosure information not submitted.

• Interventional Oncology Complication

  Wednesday, March 8, 2023
  1:39 PM – 1:52 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• New perspectives in non vascular IR in women’s health

  Wednesday, March 8, 2023
  3:00 PM – 4:30 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• Percutaneous ablation of breast tumors

  Wednesday, March 8, 2023
  3:00 PM – 3:15 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)

• Total Lesion Glycolysis and the Impact of Tumor Absorbed Dose Following Radioembolization of Breast Cancer Liver Metastases

  Wednesday, March 8, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): Boston Scientific, Inc.: Speaking and Teaching (Terminated, March 31, 2022); Hologic, Inc: Consultant (Terminated, January 30, 2022); Pfizer: Speaking and Teaching (Terminated, November 30, 2022)